ArticleFrontiers in neuroscience2026
Diagnostic value of diffusion kurtosis imaging for brain injury in term neonates with hypoxic-ischemic encephalopathy.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neonatal hypoxic-ischemic encephalopathy (HIE) stands as a primary cause of neonatal brain injury, mortality, and long-term neurodevelopmental impairment, imposing a considerable burden on public health systems worldwide. Despite advances in clinical practice, accurate early diagnosis and reliable severity stratification of HIE remain formidable challenges when relying solely on conventional neuroimaging modalities. Materials and methods: A cohort of 66 term neonates with clinically confirmed HIE and 25 age-matched healthy controls underwent cranial magnetic resonance imaging (MRI) combined with diffusion kurtosis imaging (DKI) within the first 28 days of life. A region-of-interest (ROI)-based quantitative analysis was conducted to quantify kurtosis and diffusion metrics across distinct white matter and deep gray matter regions. The diagnostic utility and severity-stratifying capacity of these DKI parameters were evaluated using receiver operating characteristic (ROC) curve analysis, while their potential correlations with 1-min and 5-min Apgar scores were further explored. Results: ROI-based analysis revealed significant differences in DKI parameters between neonates with HIE and healthy controls across multiple brain regions. Notably, DKI parameters derived from deep gray matter exhibited superior diagnostic performance and severity stratification capacity, with several kurtosis indices achieving an area under the ROC curve (AUC) greater than 0.90. Subgroup comparisons further demonstrated that specific DKI parameters differed significantly between mild and moderate, and between mild and moderate-to-severe HIE cases. Among all measured indices, the mean kurtosis of the corpus callosum yielded relatively high discriminative efficacy. Additionally, a subset of DKI parameters showed significant correlations with Apgar scores, with a greater number of parameters correlating strongly with the 5-min Apgar score. Conclusion: DKI yields robust quantitative biomarkers that facilitate the accurate diagnosis and reliable severity stratification of neonatal HIE, with deep gray matter emerging as a pivotal indicator of brain injury severity. These findings underscore the potential value of advanced diffusion-weighted imaging techniques in enabling early risk stratification and standardized assessment of neonatal brain injury, which carries profound implications for the optimization of public health-oriented neonatal care strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.